Jerusalem, 8 May, 2025 (TPS-IL) — HT Vista Ltd. has launched a major update to its AI-driven cancer screening device for dogs, adding a diagnostic capability when specificity exceeds 90%. The update introduces a new scoring system—low, moderate, or high cancer risk—making results easier for veterinarians to interpret and discuss with pet owners.

Built on validated global data, the device achieves a 98% negative predictive value and can now identify specific benign and malignant tumors. HT Vista will showcase the enhanced technology at the upcoming BSAVA Congress 2025 in Rio de Janeiro.

TPS

See Full Bio